학술논문
Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients
Document Type
Article
Author
Franssen, L.E.; Nijhof, I.S.; Emmelot, M.; Van Kessel, B.; Zweegman, S.; Lokhorst, H.M.; Mutis, T.; Van De Donk, N.W.C.J.; Bjorklund, C.C.; Chiu, H.; Thakurta, A.; Qian, X.; Doorn, R.; Van Velzen, J.; Bloem, A.C.; Levin, M.-D.; Bos, G.M.J.; Broijl, A.; Sonneveld, P.; Klein, S.K.; Koene, H.R.; Beeker, A.; Faber, L.M.; Van Der Spek, E.; Raymakers, R.
Source
In: Oncotarget . (Oncotarget, 1 September 2018, 9(74):34009-34021)
Subject
Language
English
ISSN
19492553